Overview
- Representatives voted 88-51 to advance HB 25, which would let pharmacies sell ivermectin for human use without a prescription.
- A companion measure has broad Republican sponsorship in the Senate, which approved a similar bill in 2023.
- Backers, including Speaker Dustin Burrows, frame the change as expanding medical freedom and say pharmacy access is safer than purchases from feed stores.
- Democrats argued the policy risks harm, noting no major medical groups back over-the-counter sales and citing FDA and WHO guidance against using ivermectin for COVID-19, as well as a 2021 spike in poisonings in Texas.
- Supporters have cited a 2021 review suggesting benefits for COVID-19, but a large meta-analysis published in May 2025 found no meaningful patient outcome improvements from ivermectin.